How to Help Your Patients Find Viloxazine in Stock: A Provider's Guide

Updated:

February 27, 2026

Author:

Peter Daggett

Summarize this blog with AI:

A practical guide for healthcare providers on helping patients find Viloxazine (Qelbree) in stock. Includes workflow tips, pharmacy strategies, and alternative options for 2026.

How to Help Your Patients Find Viloxazine in Stock

Your patients are frustrated, and they're turning to you for help. Finding Viloxazine (Qelbree) at a pharmacy has been a persistent challenge in 2026, and as their prescriber, you're in a unique position to make a difference. This guide provides actionable strategies you can implement in your practice to help patients access this important non-stimulant ADHD medication.

The Current State of Viloxazine Availability in 2026

Viloxazine is not on the FDA's drug shortage list. Supernus Pharmaceuticals continues to manufacture Qelbree without reported production constraints. The challenge is at the distribution and pharmacy level — the medication exists in the supply chain but is not consistently stocked at all pharmacies due to its brand-only status and high cost.

This means the problem is solvable: it's a matter of connecting patients with pharmacies that have Viloxazine in stock, rather than waiting for a manufacturing issue to resolve.

Why Your Patients Still Can't Find Viloxazine

Wholesaler Allocation Limits

Pharmacies purchase medications through wholesalers who allocate inventory based on purchasing history. A pharmacy that hasn't previously stocked Viloxazine regularly will have a lower allocation, making it difficult to get even when they try to order it for a specific patient.

Demand Concentration

The continued interest in non-stimulant ADHD treatments — partly driven by ongoing stimulant availability challenges — has concentrated demand for Viloxazine. In areas with multiple prescribers shifting patients to non-stimulants, local pharmacies may be unable to keep up.

Pharmacy Economics

At $350–$500 per month retail, Viloxazine represents a significant inventory investment for pharmacies. Many choose not to stock it unless they have a confirmed prescription, which creates delays for patients. This is particularly true at chain pharmacies that follow corporate inventory management protocols.

Brand-Only Status

Without a generic alternative, every Viloxazine prescription must be filled with Qelbree. Generic medications are stocked much more broadly because they cost pharmacies less to maintain in inventory. Until a generic enters the market, distribution will remain more limited than typical ADHD medications.

What You Can Do to Help Your Patients

1. Use the Medfinder Provider Portal

The Medfinder provider portal allows you to search for pharmacies with Viloxazine in stock on behalf of your patients. Their dedicated support team contacts pharmacies to verify availability, saving your staff time and giving patients a concrete next step. Consider making this a standard part of your prescribing workflow for Viloxazine.

2. Advise Patients to Plan Ahead

Educate patients to contact their pharmacy at least one week before they need a refill. This gives the pharmacy time to order Viloxazine from their wholesaler if it's not currently in stock. Many of the crisis calls your office receives could be prevented with this simple planning step.

3. Recommend Trying Independent Pharmacies

Independent pharmacies frequently use different wholesalers than chain pharmacies and have more flexibility in ordering decisions. They may be able to source Viloxazine more easily and are often more willing to make special orders for regular patients. Maintaining a list of independent pharmacies in your area that reliably stock Viloxazine is a valuable practice resource.

4. Prescribe with Flexibility in Mind

When clinically appropriate, consider whether dose flexibility could help with access:

  • If a patient needs 400 mg daily and the 200 mg capsule is available but not 400 mg, two 200 mg capsules could work
  • If one dose strength is unavailable, discuss whether a different available dose could serve as a temporary bridge
  • Always document the clinical rationale for any dose adjustments

Important: Only make dose-related changes when clinically appropriate and with proper patient counseling.

5. Ensure Patients Know About Savings Programs

Cost can compound the access problem — even when patients find a pharmacy with Viloxazine, they may not fill the prescription due to high copays. Proactively connect patients with:

  • Qelbree Savings Card: Copay as low as $0 for eligible commercially insured patients
  • Supernus Cares PAP: Free medication for qualifying uninsured or underinsured patients
  • Discount cards: GoodRx, SingleCare, and other programs may offer savings for cash-pay patients

Alternative Options to Discuss with Patients

When Viloxazine is genuinely unavailable and a patient needs immediate treatment, consider these non-stimulant alternatives:

  • Atomoxetine (Strattera): The closest pharmacological alternative — also a norepinephrine reuptake inhibitor. Widely available as a generic at $30–$80/month. Lacks Viloxazine's serotonin-modulating activity. Takes 4–6 weeks for full effect.
  • Guanfacine ER (Intuniv): An alpha-2 agonist approved for pediatric ADHD (ages 6–17). Generic available at $20–$60/month. Particularly useful for hyperactivity and impulsivity symptoms. May cause sedation.
  • Clonidine ER (Kapvay): Another alpha-2 agonist option for pediatric ADHD. Generic available at $15–$50/month. More sedating than Guanfacine; may benefit patients with comorbid sleep difficulties or tics.

When discussing alternatives, frame the conversation around temporary bridging rather than permanent switching, unless the patient and clinical situation warrant a full change in treatment.

Streamlining Your Practice Workflow

To reduce the burden on your practice and improve patient outcomes, consider these workflow improvements:

Designate a Point Person for Medication Access

Assign a staff member (medical assistant, nurse, or care coordinator) as the go-to person for medication access issues. This person can manage savings card enrollments, contact the Medfinder provider portal, and field patient calls about availability — freeing up clinician time.

Build Availability Checks into Your Prescribing Process

Before sending a Viloxazine prescription to a pharmacy, consider using the Medfinder provider portal to verify the pharmacy has it in stock. A quick check upfront can prevent the frustration of a rejected or delayed fill.

Keep a Reliable Pharmacy List

Maintain an internal list of pharmacies in your area that consistently stock Viloxazine. Update it periodically as availability shifts. Share this list with patients at the point of prescribing, not after they've already had trouble filling the prescription.

Proactive Prior Authorization

Since most insurers require PA for Viloxazine, submit prior authorization documentation as soon as the decision to prescribe is made — don't wait until the patient gets a denial at the pharmacy. Include clear documentation of previous treatment trials and clinical rationale for a non-stimulant option.

Final Thoughts

Viloxazine availability challenges are manageable with proactive planning and the right tools. As a prescriber, your involvement can make the difference between a patient who gets their medication and one who gives up in frustration.

Key takeaways for your practice:

  1. Use the Medfinder provider portal to locate Viloxazine in stock for patients
  2. Advise patients to plan refills one week ahead
  3. Maintain a list of reliable pharmacies that stock Viloxazine
  4. Connect every patient with the Qelbree savings card or PAP
  5. Have non-stimulant alternatives ready as a contingency plan

For the clinical briefing on Viloxazine supply chain dynamics, see our provider shortage briefing. To share with patients, direct them to our patient shortage update.

How can I help my patient find Viloxazine in stock?

Use the Medfinder provider portal (medfinder.com/providers) to search for pharmacies with Viloxazine in stock on behalf of your patient. You can also recommend independent pharmacies, advise patients to plan refills one week ahead, and maintain an internal list of pharmacies that reliably stock Qelbree.

Is Viloxazine still on shortage in 2026?

No, Viloxazine is not on the FDA drug shortage list. The availability issues are localized — driven by brand-only status, high cost discouraging pharmacy stocking, and wholesaler allocation limits. The medication is being manufactured and distributed by Supernus Pharmaceuticals without production constraints.

What non-stimulant alternatives to Viloxazine can I prescribe?

The most common non-stimulant alternatives are Atomoxetine (Strattera) — the closest pharmacological match, available as a generic; Guanfacine ER (Intuniv) — an alpha-2 agonist for pediatric ADHD; and Clonidine ER (Kapvay) — another alpha-2 agonist option. All three have generic versions at significantly lower cost.

What should I do if my patient cannot afford Viloxazine?

Connect patients with the Qelbree Savings Card (copays as low as $0 for commercially insured patients), the Supernus Cares Patient Assistance Program (free medication for qualifying uninsured/underinsured patients), or discount card programs like GoodRx or SingleCare. If cost remains prohibitive, consider generic Atomoxetine ($30–$80/month) as a therapeutic alternative.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
99% success rate
Fast-turnaround time
Never call another pharmacy